Stake Purchase • Life Science

Gedeon Richter Invests In Granata Bio

On May 13, 2025, Gedeon Richter invested in life science company Granata Bio

Investment Context

This is Gedeon Richter’s 1st transaction in the Life Science sector.
This is Gedeon Richter’s 1st transaction in the United States.
This is Gedeon Richter’s 1st transaction in Massachusetts.

Explore All 282 Stake Purchase Life Science Deals - Search the Database Free

Investment Summary
Date	May 13, 2025
Target	Granata Bio
Sector	Life Science
Investor(s)	Gedeon Richter
Deal Type	Stake Purchase

Target Company

Granata Bio

Duxbury, Massachusetts, United States

Granata Bio is a U.S.-based biopharmaceutical company dedicated to advancing innovation in women's health and infertility. Granata Bio's pipeline includes a range of fertility therapies, with collaborations spanning multiple drug classes to address unmet needs in reproductive medicine. Granata Bio was formed in 2018 and is based in Duxbury, Massachusetts.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Investor Overview 1

Investor

Gedeon Richter

Budapest, Hungary

Category	Company
Founded	1901
Sector	Life Science
Employees	10,943
Revenue	857.5B HUF (2024)

DESCRIPTION

Gedeon Richter is a multinational company that is vertically integrated and involves pharmaceutical manufacturing, research and development, sales, and marketing. Gedeon Richter was founded in 1901 and is based in Budapest, Hungary.

Deal Context for Investor	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Stake Purchase	1 of 1
State: Massachusetts	1 of 1
Country: United States	1 of 1
Year: 2025	1 of 1

Explore Related M&A Activity

Life Science M&A - Stake Purchase M&A Deals - Massachusetts M&A - United States M&A - 2025 M&A